These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17547563)

  • 1. Balance module allows consistent monitoring and documentation of the pooling process for nucleic acid amplification technology testing.
    Hourfar MK; Koller M; Roth WK; Kehrli R; Seifried E; Schmidt M
    Vox Sang; 2007 Jul; 93(1):37-41. PubMed ID: 17547563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories.
    Walker S; Dimech W; Kiely P; Smeh K; Francis B; Karakaltsas M; Dax EM
    Vox Sang; 2009 Nov; 97(4):309-16. PubMed ID: 19682349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.
    Kleinman SH; Williams JD; Robertson G; Caglioti S; Williams RC; Spizman R; Morgan L; Tomasulo P; Busch MP
    Transfusion; 2009 Jun; 49(6):1160-70. PubMed ID: 19320866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus in blood donations, Puerto Rico, 2005.
    Mohammed H; Linnen JM; Muñoz-Jordán JL; Tomashek K; Foster G; Broulik AS; Petersen L; Stramer SL
    Transfusion; 2008 Jul; 48(7):1348-54. PubMed ID: 18503611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.
    Biggerstaff BJ; Petersen LR
    Transfusion; 2009 Jun; 49(6):1151-9. PubMed ID: 19309472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype.
    Galel SA; Webster J; Roa L
    Transfusion; 2008 Jul; 48(7):1486-94. PubMed ID: 18466179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology.
    Scuracchio PS; Poli MC; Lemos MM; Oliveira Filho AG; Salles NA; Chamone DA; Magri M; Cavalcante NJ; Collela R
    Transfus Med; 2007 Jun; 17(3):200-4. PubMed ID: 17561863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; de Wit GA; Bonsel GJ; van Hout BA
    Transfusion; 2009 Feb; 49(2):311-9. PubMed ID: 19389213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
    Polizzotto MN; Wood EM; Ingham H; Keller AJ;
    Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations.
    Novack L; Sarov B; Goldman-Levi R; Yahalom V; Safi J; Soliman H; Orgel M; Yaari A; Galai N; Pliskin JS; Shinar E
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):787-92. PubMed ID: 18486172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G
    Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.
    Linauts S; Saldanha J; Strong DM
    Transfusion; 2008 Jul; 48(7):1376-82. PubMed ID: 18422847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.